We are very grateful that we have received funding from several organizations. These grants supported the development of the CytoSMART Omni and the corresponding analysis tools:
The Operational Program Zuid-Nederland (OPZuid) from the European Fund for Regional Development (EFRO; Europees Fonds voor Regionale Ontwikkeling) supported the drug screening, specifically for heart failure, project using CytoSMART Omni, also using the image analysis software complementing the CytoSMART Omni. A current problem in drug development is that side effects related to heart failure can only be diagnosed at a late stage. This project will provide the opportunity to investigate the influence of drugs on heart cells with less cell material, which leads to personalized advice and drug development. The results of this project lead to a unique positioning of their high-tech products for CytoSMART, enabling rapid penetration within the pharmaceutical industry. To achieve this, CytoSMART builds on its cost-effective microscopy solutions, utilizing modern technologies.